The statistic shows the global cancer immunotherapy market in 2017, distributed by world region. In that year, North America was reported to have a market share of almost 45 percent within the global cancer immunotherapy market.
Global cancer immunotherapy market share by region in 2017
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
BIS Research. (March 25, 2019). Global cancer immunotherapy market share by region in 2017 [Graph]. In Statista. Retrieved December 22, 2024, from https://www.statista.com/statistics/1016943/cancer-immunotherapy-market-share-by-world-region/
BIS Research. "Global cancer immunotherapy market share by region in 2017." Chart. March 25, 2019. Statista. Accessed December 22, 2024. https://www.statista.com/statistics/1016943/cancer-immunotherapy-market-share-by-world-region/
BIS Research. (2019). Global cancer immunotherapy market share by region in 2017. Statista. Statista Inc.. Accessed: December 22, 2024. https://www.statista.com/statistics/1016943/cancer-immunotherapy-market-share-by-world-region/
BIS Research. "Global Cancer Immunotherapy Market Share by Region in 2017." Statista, Statista Inc., 25 Mar 2019, https://www.statista.com/statistics/1016943/cancer-immunotherapy-market-share-by-world-region/
BIS Research, Global cancer immunotherapy market share by region in 2017 Statista, https://www.statista.com/statistics/1016943/cancer-immunotherapy-market-share-by-world-region/ (last visited December 22, 2024)
Global cancer immunotherapy market share by region in 2017 [Graph], BIS Research, March 25, 2019. [Online]. Available: https://www.statista.com/statistics/1016943/cancer-immunotherapy-market-share-by-world-region/
